Researchers developed a predictive model for identifying admissions of patients with cancer who were potentially suitable for in-patient level care at home, or hospital at home
Study results show both clinician- and patient-reported performance status are useful for predicting morbidity and mortality in patients with advanced cancer receiving chemotherapy.
Study suggests provider characteristics, like gender and geographic region may play a role in predicting treatment planning of radiation oncology procedures.
The FDA granted approval to fam-trastuzumab deruxtecan-nxki for adults with locally advanced or metastatic HER2-positive gastric or gastroesophageal adenocarcinoma.
Results from a single-center study show payers incur the bulk of monthly PARP inhibitor cost for ovarian cancer.